comparemela.com

Latest Breaking News On - Finox biotech - Page 1 : comparemela.com

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical.

Plan les ouatesFranche comtérCatarina edfjLuigi marroMerck seronoErnest loumayeEconomical statistic sciencesArticles of associationCompensation committeeMaster of business administrationSwiss exchangeUniversity in lyonObseva executive committeeCommittee for the fiscal yearVoisin life sciences consultingStrategy development

ObsEva SA: Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland - June 8, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for

Mecklenburg vorpommernPlan les ouatesFranche comtérErnest loumayeMerck seronoStefan klotterLuigi marroCatarina edfjMaster of business administrationCompensation committeeEconomical statistic sciencesArticles of associationStrategy developmentVoisin life sciences consultingCommittee for the fiscal yearObseva executive committee

The Worldwide Male Hypogonadism Industry is Expected to Reach $5 Billion by 2030

/PRNewswire/ The "Male Hypogonadism Market By Drug Delivery, By Therapy, By Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has.

United statesFinox biotecAsia pacificEli lillyLaura woodMerck coTeva pharmaceutical industries ltdMerck co incEli lily companyFerring holdingsPfizer incBayer agEndo iternationalOffice hours callE st office hours callEndo international

ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Shauna dillonLuigi marroBrian ocallaghanJoyce allaireMaster of business administrationExchange commissionVoisin life sciences consultingStrategy developmentEconomical statistic sciencesSwiss exchangeChief transformation officerExecutive committeeCommercial operational readinessBriano callaghanChief executive officerChief financial officer

ObsEva SA: ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - September 30, 2021 - ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing

Shauna dillonLuigi marroBrian ocallaghanJoyce allaireMaster of business administrationExchange commissionVoisin life sciences consultingStrategy developmentEconomical statistic sciencesSwiss exchangeChief transformation officerExecutive committeeCommercial operational readinessBriano callaghanChief executive officerChief financial officer

vimarsana © 2020. All Rights Reserved.